About US
Contact us
-
ADA: 'Impressed and pleased,' Boehringer trumpets latest Jardiance win at ADAJardiance partners Eli Lilly and Boehringer Ingelheim have worked hard to establish their medicine as a competitive force in the diabetes and cardiovascular treatment landscapes. Now, they're rolling2022/6/7
-
ASCO: Merck exec on his first ASCO, Keytruda's journey and new dataNew data presented at the 2022 American Society of Clinical Oncology (ASCO) annual meeting reaffirm Keytruda’s potentialagainst stage 2 skin cancer, an exec said. In an interview, he reflected on his2022/6/7
-
FDA approves Novartis’ cell therapy for follicular lymphoma in adultsNovartis has obtained acceleratedapprovalfrom the US Food and Drug Administration (FDA) for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat adults with relapsed or refractory (r/r) follicu2022/6/2
-
China grants approval for GSK’s two-dose HPV vaccine for girlsChina’s National Medical Products Administration (NMPA) has grantedapprovalfor GlaxoSmithKline’s (GSK) two-dose vaccine schedule, Cervarix, in girls between the age of nine to 14 years to prevent cer2022/6/2
-
China grants approval for GSK’s two-dose HPV vaccine for girlsChina’s National Medical Products Administration (NMPA) has grantedapprovalfor GlaxoSmithKline’s (GSK) two-dose vaccine schedule, Cervarix, in girls between the age of nine to 14 years to prevent cer2022/5/31
-
FDA approves Novartis’ cell therapy for follicular lymphoma in adultsNovartis has obtained acceleratedapprovalfrom the US Food and Drug Administration (FDA) for its CAR-T cell therapy Kymriah (tisagenlecleucel) to treat adults with relapsed or refractory (r/r) follicu2022/5/31
-
conference Review: third LORENZ Connect conferenceLORENZ Connect 2022: Valuable RA insights for 380 attendees in 32 countries! Our third LORENZ Connect conference has come to an end. We would like to thank all of our speakers for the time and effor2022/5/27
-
GlaxoSmithKline trade secret theft case strikes down Swiss scientist, its 5th target, in convictionA federal investigation into a criminal ring that stole trade secrets from GlaxoSmithKline for a Chinese biotech has claimed its fifth target. Gongda Xue, a Chinesecitizen and former scientist2022/5/26
-
Takeda, bracing for Vyvanse patent loss, makes strides on debt goal and pivots its focus to launchesEver since Takeda closed its Shire takeover, the company has prioritized cutting its debt. After selling off some dispensable assets, the Japanese pharma is moving closer to its goal and is increasin2022/5/26
-
Merck KGaA lines up 370 new jobs with $470M manufacturing boost in IrelandGermany’s Merck KGaA—fresh off its buyout of mRNA player Exelead—is throwing down almost half a billion dollars more to grow its manufacturing footprint on the Emerald Isle. Merck KGaA will inv2022/5/24